Genomeup
VerifiedAI platform for enabling doctors and clinical institutions to diagnose and treat rare genetic diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$5—7m (Dealroom.co estimates Mar 2023.)
Company register number RM1506613
Rome Lazio (HQ)
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 22663 % | 82 % | 82 % | 35 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | (35180 %) | 13 % | (161 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 2 % | - | (15266 %) | 11 % | (153 %) | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | $0.0 | round |
| investor investor investor | $0.0 | round | |
| N/A | $0.0 Valuation: $0.0 -10.3x EV/LTM EBITDA | round | |
| investor | $0.0 Valuation: $0.0 7500.0x EV/LTM Revenues -21.3x EV/LTM EBITDA | round | |
| investor investor investor investor | $0.0 Valuation: $0.0 36.9x EV/LTM Revenues -22.9x EV/LTM EBITDA | round | |
| investor investor investor investor investor investor | $0.0 | round | |
| N/A | €638k | Convertible | |
| Total Funding | 000k | ||
Related Content
Recent News about Genomeup
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.